Literature DB >> 22209468

Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria.

Joseph O Falkinham1, Richard V Macri, Bhadreshkumar B Maisuria, Marcelo L Actis, Eko W Sugandhi, André A Williams, Alyson V Snyder, Faunice R Jackson, Michael A Poppe, Liang Chen, Krithika Ganesh, Richard D Gandour.   

Abstract

The anti-mycobacterial activities of nine series of dicarboxyl and tricarboxyl dendritic amphiphiles with one alkyl, two alkyl, and cholestanyl tails against Mycobacterium abscessus, Mycobacterium avium, Mycobacterium chelonae, Mycobacterium marinum and Mycobacterium smegmatis have been measured. The dendritic amphiphiles overcame the limited aqueous solubility of natural long-chain fatty acids, alcohols, and amines to enable profiling the susceptibilities of the different mycobacterial species to the physicochemical properties of these amphiphiles. Several dendritic amphiphiles showed strong anti-mycobacterial activity with high critical micelle concentrations and low hemolytic activities thereby offering platforms for the development of antibiotics of higher activity against nontuberculous mycobacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209468     DOI: 10.1016/j.tube.2011.12.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  7 in total

1.  Antimycobacterial furofuran lignans from the roots of Anemopsis californica.

Authors:  Robert O Bussey; Arlene A Sy-Cordero; Mario Figueroa; Fredrick S Carter; Joseph O Falkinham; Nicholas H Oberlies; Nadja B Cech
Journal:  Planta Med       Date:  2014-03-31       Impact factor: 3.352

2.  Transition metal-α-amino acid complexes with antibiotic activity against Mycobacterium spp.

Authors:  George W Karpin; Joseph S Merola; Joseph O Falkinham
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

3.  Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes from a Bionectria sp. (MSX 47401).

Authors:  Mario Figueroa; Huzefa Raja; Joseph O Falkinham; Audrey F Adcock; David J Kroll; Mansukh C Wani; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2013-06-19       Impact factor: 4.050

4.  Mycobacterium abscessus drug discovery using machine learning.

Authors:  Alan A Schmalstig; Kimberley M Zorn; Sebastian Murcia; Andrew Robinson; Svetlana Savina; Elena Komarova; Vadim Makarov; Miriam Braunstein; Sean Ekins
Journal:  Tuberculosis (Edinb)       Date:  2022-01-20       Impact factor: 3.131

Review 5.  Challenges of NTM Drug Development.

Authors:  Joseph O Falkinham
Journal:  Front Microbiol       Date:  2018-07-18       Impact factor: 5.640

Review 6.  Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.

Authors:  Saloni Saxena; Herman P Spaink; Gabriel Forn-Cuní
Journal:  Biology (Basel)       Date:  2021-01-29

7.  Identification of the Target for a Transition Metal-α-Amino Acid Complex Antibiotic Against Mycobacterium smegmatis.

Authors:  George W Karpin; Joseph S Merola; Joseph O Falkinham
Journal:  Front Pharmacol       Date:  2021-06-25       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.